FORBES MEDI-TECH INC
|
What other FMI shareholders are saying:- |
Forbes Medi-Tech is a bio-technology company dedicated to the development of valuable pharmaceutical compounds from forest industry by-products. Within the development pipeline are a number of products that offer potential entry into billion dollar markets. This research in plant sterols has yielded significant commercial opportunities to Forbes representing potential in the following billion dollar markets: |
Analysts Research reports from Loewen, Ondaatje & McCutcheon Ltd And Union Securities Ltd Coverage initiated by newspapers independent of the company |
|
Product/(Alliance) |
Market |
Market Partner |
Market size ($US) |
|
|
Phytrol |
Cholesterol-lowering food additive |
Novartis |
$10B potential |
|
|
Cadiorex |
Cholesterol-lowering prescription drug |
|
$8B projected at market entry in 2001 |
|
|
AD & ADD |
Steroid precursors |
Cargill |
$1B market |
|
|
Hormones and Female Contraceptive Agent |
'Higher value" steroid products |
|
$2B - $4B estimated |
|